Petros Pharmaceuticals, Inc. Share Price
Equities
PTPI
US71678J2096
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.415 USD | -2.15% | -9.29% | -70.57% |
Sales 2024 * | 5.41M 422M | Sales 2025 * | 5.48M 427M | Capitalization | 2.91M 227M |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.48B | Net income 2025 * | -15M -1.17B | EV / Sales 2024 * | 0.54 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.53 x |
P/E ratio 2024 * |
-0.1
x | P/E ratio 2025 * |
-0.13
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.41% |
1 day | -2.15% | ||
1 week | -9.29% | ||
Current month | -9.29% | ||
1 month | -9.39% | ||
3 months | -55.14% | ||
6 months | -69.49% | ||
Current year | -70.57% |
Managers | Title | Age | Since |
---|---|---|---|
John Shulman
CEO | Chief Executive Officer | 61 | - |
Fady Boctor
PSD | President | 47 | 30/11/20 |
Mitchell Arnold
AUD | Comptroller/Controller/Auditor | 61 | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Shulman
CEO | Chief Executive Officer | 61 | - |
Bruce Bernstein
BRD | Director/Board Member | 60 | 30/11/20 |
Joshua Silverman
BRD | Director/Board Member | 54 | 31/12/19 |
Date | Price | Change | Volume |
---|---|---|---|
05/07/24 | 0.415 | -2.15% | 193,105 |
03/07/24 | 0.4241 | -1.35% | 104,539 |
02/07/24 | 0.4299 | -0.72% | 161,814 |
01/07/24 | 0.433 | -5.36% | 104,236 |
28/06/24 | 0.4575 | +2.69% | 174,869 |
Delayed Quote Nasdaq, July 05, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.57% | 2.91M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- PTPI Stock